Potential Role of the Donor in Hepatocellular Carcinoma Recurrence After Liver Transplantation

被引:35
作者
Vagefi, Parsia A. [1 ]
Dodge, Jennifer L. [2 ]
Yao, Francis Y. [3 ]
Roberts, John P. [2 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Transplant Surg,Dept Surg, Boston, MA 02114 USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
关键词
ALLOCATION SYSTEM; HEPATITIS-C; MICROMETASTASES; RECIPIENTS; OUTGROWTH; SURVIVAL; PATIENT; MODEL; TIME; RISK;
D O I
10.1002/lt.24042
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A subset of liver transplantation (LT) recipients who undergo transplantation for hepatocellular carcinoma (HCC) will develop postoperative recurrence. There has yet to be a thorough investigation of donor factors influencing recurrence. Data regarding adult, primary LT recipients with HCC (n=5002) who underwent transplantation between January 1, 2006 and September 30, 2010 were extracted from the United Network for Organ Sharing database, and the cumulative incidence of post-LT recurrence by donor factors was subsequently estimated. Among the HCC LT recipients, 324 (6.5%) developed recurrence. An analysis of donor characteristics demonstrated a higher cumulative incidence of recurrence within 4 years of transplantation among recipients with donors60 years old (11.8% versus 7.3% with donors<60 years old, P<0.001) and with donors from a nonlocal share distribution (10.6% versus 7.4% with donors with a local share distribution, P=0.004). The latter 2 findings held true in a multivariate analysis: the risk of HCC recurrence increased by 70% for recipients of livers from donors60 years old [subhazard ratio (SHR)=1.70, 95% confidence interval (CI)=1.31-2.20, P<0.001] and by 42% for recipients of nonlocal share distribution livers (SHR=1.42, 95% CI=1.09-1.84, P=0.009) after adjustments for clinical characteristics. In conclusion, the consideration of certain donor factors may reduce the cumulative incidence of posttransplant HCC recurrence and thus improve long-term survival after LT. Liver Transpl 21:187-194, 2015. (c) 2014 AASLD.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 19 条
  • [1] Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients
    Berenguer, M
    Prieto, M
    San Juan, F
    Rayón, JM
    Martinez, F
    Carrasco, D
    Moya, A
    Orbis, F
    Mir, J
    Berenguer, J
    [J]. HEPATOLOGY, 2002, 36 (01) : 202 - 210
  • [2] Inferior Survival in Liver Transplant Recipients With Hepatocellular Carcinoma Receiving Donation After Cardiac Death Liver Allografts
    Croome, Kris P.
    Wall, William
    Chandok, Natasha
    Beck, Gavin
    Marotta, Paul
    Hernandez-Alejandro, Roberto
    [J]. LIVER TRANSPLANTATION, 2013, 19 (11) : 1214 - 1223
  • [3] Characteristics associated with liver graft failure: The concept of a donor risk index
    Feng, S
    Goodrich, NP
    Bragg-Gresham, JL
    Dykstra, DM
    Punch, JD
    DebRoy, MA
    Greenstein, SM
    Merion, RM
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (04) : 783 - 790
  • [4] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [5] Restricting Liver Transplant Recipients to Younger Donors Does Not Increase the Wait-List Time or the Dropout Rate: The Hepatitis C Experience
    Flemming, Jennifer A.
    Vagefi, Parsia A.
    Freise, Chris E.
    Yao, Francis Y.
    Terrault, Norah A.
    [J]. LIVER TRANSPLANTATION, 2014, 20 (10) : 1202 - 1210
  • [6] Liver transplantation for hepatocellular carcinoma: Impact of the MELD allocation system and predictors of survival
    Ioannou, George N.
    Perkins, James D.
    Carithers, Robert L., Jr.
    [J]. GASTROENTEROLOGY, 2008, 134 (05) : 1342 - 1351
  • [7] Patient, Center and Geographic Characteristics of Nationally Placed Livers
    Lai, J. C.
    Roberts, J. P.
    Vittinghoff, E.
    Terrault, N. A.
    Feng, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (04) : 947 - 953
  • [8] MELD Exceptions and Rates of Waiting List Outcomes
    Massie, A. B.
    Caffo, B.
    Gentry, S. E.
    Hall, E. C.
    Axelrod, D. A.
    Lentine, K. L.
    Schnitzler, M. A.
    Gheorghian, A.
    Salvalaggio, P. R.
    Segev, D. L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (11) : 2362 - 2371
  • [9] Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
    Mazzaferro, V
    Regalia, E
    Doci, R
    Andreola, S
    Pulvirenti, A
    Bozzetti, F
    Montalto, F
    Ammatuna, M
    Morabito, A
    Gennari, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 693 - 699
  • [10] Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
    Roayaie, S
    Schwartz, JD
    Sung, MW
    Emre, SH
    Miller, CM
    Gondolesi, GE
    Krieger, NR
    Schwartz, ME
    [J]. LIVER TRANSPLANTATION, 2004, 10 (04) : 534 - 540